Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
Cognitive Remediation of Executive Dysfunction - Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
1 other identifier
interventional
83
1 country
1
Brief Summary
About 85% of patients with schizophrenia have cognitive impairments, executive functions being particularly affected. Executive dysfunction, and cognitive deficits in general, are important predictors of functional outcomes, including social problem solving, activities of daily living, life satisfaction, and the ability to return to work or school.The main objective of the current study is to examine the efficacy of group-based Goal Management Training (GMT) for patients with broad schizophrenia spectrum disorders or high risk individuals with executive deficits. The short term goals are to investigate whether GMT can improve participants' ability to organize and achieve goals in everyday life in addition to improving aspects of emotional health. A long-term goal would be to establish an evidence base for nonpharmacological interventions for patients with broad schizophrenia spectrum disorders or high risk for schizophrenia. Main research questions: (1) Does a RCT with GMT delivered to patients with broad schizophrenia spectrum disorders or high risk for schizophrenia result in improved executive functioning, measured by self-reported and/or objective measures of executive functions? (2) Does GMT result in improved goal attainment in everyday life, social- and real world functioning? (3) Does GMT have a positive impact on the patients' emotional health? (4) Are there specific characteristics in patients with broad schizophrenia spectrum disorders or high risk for schizophrenia that are associated with better treatment benefit from GMT?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started May 2017
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2017
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedStudy Start
First participant enrolled
May 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFebruary 10, 2021
February 1, 2021
3.6 years
January 16, 2017
February 9, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Behavior Rating Inventory for Executive Functions
Assessing change
Baseline, immediately post-intervention and 6 months follow-up
Conners Continuous Performance Test III
Assessing change
Baseline, immediately post-intervention and 6 months follow-up
Positive and Negative Syndrome Scale
Assessing change
Baseline, immediately post-intervention and 6 months follow-up
Secondary Outcomes (14)
Global Assessment of Functioning-Split Version
Baseline, immediately post-intervention and 6 months follow-up
The Hotel Task
Baseline, immediately post-intervention and 6 months follow-up
Delis Kaplan Executive Function System (D-KEFS) subtests
Baseline, immediately post-intervention and 6 months follow-up
Digit span and Letter-number sequencing
Baseline, immediately post-intervention and 6 months follow-up
Iowa Gambling Task
Baseline, immediately post-intervention and 6 months follow-up
- +9 more secondary outcomes
Study Arms (2)
Goal Management Training
EXPERIMENTALCognitive rehabilitation
Waiting list
NO INTERVENTIONInterventions
Metacognitive strategy training where the primary objective is to stop ongoing behavior to define goal hierarchies and monitor performance
Eligibility Criteria
You may qualify if:
- Being consecutively referred to treatment for a DSM-IV diagnosis of broad schizophrenia spectrum psychosis (schizophrenia, schizophreniform disorder and schizoaffective disorder) or high risk for psychosis or being treated for psychotic disorder for less than 5 years.
- Reporting executive problems through (a) structured interview, or (b) self-report, i.e. BRIEF scale T-score \< 55.
You may not qualify if:
- Reported ongoing alcohol or substance abuse.
- Premorbid neurological disease or insult and/or comorbid neurological disease. ° Severe cognitive problems interfering with the capacity to participate.
- IQ below 70.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sykehuset Innlandet HFlead
- University of Oslocollaborator
Study Sites (1)
Sykehuset Innlandet Reinsvoll
Reinsvoll, 2840, Norway
Related Publications (3)
Orm S, Oie MG, Haugen I. Iowa Gambling Task performance in individuals with schizophrenia: the role of general versus specific cognitive abilities. Front Psychiatry. 2024 Dec 10;15:1454276. doi: 10.3389/fpsyt.2024.1454276. eCollection 2024.
PMID: 39720440DERIVEDOie MB, Haugen I, Stubberud J, Oie MG. Effects of Goal Management Training on self-efficacy, self-esteem, and quality of life for persons with schizophrenia spectrum disorders. Front Psychol. 2024 Mar 7;15:1320986. doi: 10.3389/fpsyg.2024.1320986. eCollection 2024.
PMID: 38515967DERIVEDHaugen I, Stubberud J, Haug E, McGurk SR, Hovik KT, Ueland T, Oie MG. A randomized controlled trial of Goal Management Training for executive functioning in schizophrenia spectrum disorders or psychosis risk syndromes. BMC Psychiatry. 2022 Aug 28;22(1):575. doi: 10.1186/s12888-022-04197-3.
PMID: 36031616DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merete G Øie, Phd
Sykehuset Innlandet HF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2017
First Posted
February 9, 2017
Study Start
May 18, 2017
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
February 10, 2021
Record last verified: 2021-02